Video Library

This presentation provides an overview of various long-term effects that may occur after an autologous stem cell transplant, and provides strategies and advice for how these effects might be managed.

Bone marrow/stem cell transplant survivors need a comprehensive plan for long-term follow-up care. This presentation discusses the challenges survivors face in accessing this care and strategies to overcome these challenges.

This presentation discusses what a clinical trial is, why they are necessary, the phases of a clinical research trials, how they are reviewed to ensure patient safety, the process involved in participating in a clinical trial, and where one can go to receive further information about clinical trials. 

This presentation outlines the importance of long-term follow-up care after a bone marrow/stem cell transplant using donor cells (allogeneic transplant) focused on supportive care for side effects post-transplant, identifying new health issues early, and providing resources and guidance to ensure the patient is experiencing their optimal quality of life after treatment.

Maintenance therapy is now standard of care treatment in newly diagnosed patients with multiple myeloma. This presentation describes what maintenance therapy is, current medications being utilized for maintenance, and what current clinical trials are hoping to reveal.

Summary and Transcription Coming Soon

Older age used to be a prohibitive factor for receiving a bone marrow/stem cell transplant, but this is changing. This presentation reviews the evidence that some older patients can be good candidates for transplant as well as CAR T-cell therapy and how to assess their risks.

This presentation gives a thorough description of the CAR T-cell therapy process for B-cell acute lymphoblastic leukemia (B-cell ALL), and discusses short- and long-term side effects and toxicities, expected outcomes, and ongoing research related to this therapy.

CAR T cell therapy has become an increasingly common treatment for patients with diffuse large B-cell lymphoma, (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma. This presentation discusses how it works, who is a good candidates for CAR T-cell therapy, and the risks and benefits of the treatment.

This presentation discusses CAR T-cell therapy for multiple myeloma. It explains what CAR T-cell therapy is, the process, and what clinical trials are indicating in regards to short- and long-term side effects, patient outcomes, and quality of life.

Graft-versus-host-disease (GVHD) can be a significant problem after stem cell transplantation. This presentation discusses what GVHD is, risk factors for developing it and recent advances in the prevention and treatment of GVHD.

Graft-versus-host-disease (GVHD) can be a major complication after bone marrow/stem cell transplantation. This presentation describes the types of GVHD, its typical effects on patients, and several promising new treatments for this condition.